It was designed as an equivalence trial for efficacy and was designed to show potential safety benefits with anastrozole, for example, in endometrial and thromboembolic effects. The primary objectives ...

The study analysed data from the IBIS-II prevention trial, an international randomised controlled trial of anastrozole in high-risk post-menopausal women conducted from 2003 to 2012. It found that ...

While anastrozole has been used as breast cancer medication for years, doctors can now easily prescribe it as a cancer preventative. The drug's preventative benefits have been known since 2017.

Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had ...

Anastrozole is recommended by the National Institute of Clinical Care and Excellence (NICE) as an option for preventive therapy in post-menopausal women at high risk of breast cancer, and is now also ...

Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use. The drug has been used to treat hormone-driven ...

A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study ...

“It will help doctors and women realise that it is an approved [use] and the benefits outweigh the risks.” But anastrozole’s side effects – which are the same as severe menopausal ...